摘要
Abstract
Objective To explore the clinical effect of Azithromycin combined with Terbutaline nebulization inhalation in the treatment of pediatric Mycoplasma pneumonia.Methods A total of 86 children with Mycoplasma pneumonia admitted to Xinhui District People's Hospital of Jiangmen City from June 2022 to June 2024 were selected and divided into the treatment group and the control group using the random number table method,with 43 cases in each group.The treatment group received intravenous administration of Azithromycin combined with Terbutaline nebulization inhalation,while the control group received intravenous administration of Azithromycin.The clinical efficacy,pulmonary function indicators,respiratory function indicators,and incidence of adverse reactions were compared between the two groups.Results The total effective rate,pulmonary function indicators,and respiratory function indicators of the treatment group were better than those of the control group(P<0.05).The total incidence of adverse reactions in the treatment group was lower than that in the control group(P<0.05).Conclusion The combined therapy of Azithromycin and Terbutaline nebulization inhalation can effectively improve the treatment effect of pediatric Mycoplasma pneumonia,promote the recovery of pulmonary function and respiratory function,reduce adverse reactions,and has clinical promotion value.关键词
阿奇霉素/特布他林/雾化吸入/小儿支原体肺炎Key words
Azithromycin/Terbutaline/Nebulization inhalation/Pediatric Mycoplasma pneumonia分类
医药卫生
